Navigation Links
Dozens of Lipitor Lawsuits Involving Diabetes Allegations Moved to Federal Court, Bernstein Liebhard LLP Reports
Date:11/3/2013

New York, New York (PRWEB) November 03, 2013

Court records from a around the country indicate that more plaintiffs have filed Lipitor lawsuits (http://www.thelipitorlawsuit.com/) which allege the use of the popular statin drug caused patients to develop new-onset Type 2 diabetes, Bernstein Liebhard LLP reports. According to a report published by Bluefield Daily Telegraph, 36 Lipitor lawsuits filed in West Virginia State Court were recently transferred to U.S. District Court, Southern District of West Virginia. Among other things, the complaints allege that Pfizer, Inc. never warned patients of any potential relation between changes in blood sugar levels and taking Lipitor, the Telegraph reported.*

“Our Firm continues to hear from Lipitor patients who are concerned that the use of this drug is related to their development of Type 2 diabetes. We expected this litigation to grow in the coming months, and the recent developments in West Virginia would seem to confirm those expectations,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Lipitor lawsuit consultations to anyone who may have been harmed by this medication.

Lipitor Lawsuits

The Lipitor litigation has been growing since February 2012, when the U.S. Food & Drug Administration (FDA) ordered Pfizer, Inc. to add new warnings to the Lipitor label regarding an increased risk of new-onset diabetes in patients who took the cholesterol-lowering statin. Court documents filed in October indicate that plaintiffs in federal Lipitor lawsuits have filed a second request with the U.S. Judicial Panel on Multidistrict Litigation seeking the transfer of all federally-filed claims involving similar allegations to a single federal court for pretrial proceedings. If the request is granted, all pending and future lawsuits involving Lipitor and diabetes, including those recently removed to West Virginia federal court, could be transferred to that proceeding. According to court records, plaintiffs have proposed that the federal Lipitor litigation be established in U.S. District Court, District of South Carolina, where at least 14 Lipitor lawsuits are pending and are being coordinated in an informal manner. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502 (JPML))

Additional court records filed last month also indicate that a number of similar Lipitor lawsuits have been consolidated in U.S. District Court, Southern District of Illinois, for the purposes of discovery and other pretrial proceedings. (Hines v.Pfizer Inc., No. 13-404, S.D. Ill.)

Individuals who allegedly developed Type 2 diabetes due to their use of Lipitor may be entitled to compensation for medical bills, lost wages, pain and suffering and more. Learn More about the potential association between Lipitor and diabetes at Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

*bdtonline.com/local/x2112900259/Pfizer-Inc-state-civil-complaints-removed-to-federal-court-docket/?state=taberU

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.thelipitorlawsuit.com/

Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11296208.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Best Drug Rehabilitation's New Indiana Facility to Create Dozens of Quality Long-Term Jobs
2. Lipitor Diabetes Lawsuit Filed by South Carolina Woman Who Developed Type 2 Diabetes Allegedly Due to Lipitor Use, Alonso Krangle Investigating
3. Lipitor Lawsuit News: Rottenstein Law Group Comments on FDA Approval of New Drug With Lipitor Compound
4. Lipitor Lawsuit News: US Spending on Drugs Fell For First Time in 2012, Notes Rottenstein Law Group LLP
5. Lipitor Lawsuit News: Rottenstein Law Group LLP Responds to Reports of Lipitor Giveaway
6. Lipitor News: Rottenstein Law Group LLP Comments on Boomers’ Favorite Drug
7. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
8. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
9. Lipitor Lawsuit Website Launched by Bernstein Liebhard LLP to Provide Information to the Public Regarding Lipitor Side Effects, Ongoing Litigation
10. Lipitor Lawsuit News: Judicial Panel Denies Consolidation of Federal Cases, Rottenstein Law Group LLP Reports
11. Warning of Statin Drug Lipitor’s Risk of Type 2 Diabetes Came Too Late Say Patients Filing Lipitor Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 17, 2017 , ... Focused ... innovation in the industry, according to the recent NEJM Catalyst Insights Report on ... of the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical ...
(Date:2/18/2017)... ... 2017 , ... A new directory from the Senior Veterans ... connect elderly veterans of America's armed forces to a range of senior care ... on this year's increase in the Veterans Pension with Aid & Attendance for ...
(Date:2/17/2017)... ... 2017 , ... For the first time, International Scholarship and ... floor for the 2017 HIMSS Conference & Exhibition at the Orange ... than 40,000 healthcare industry professionals are expected at the conference, where they will ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access today ... Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will ... used electronic patient signatures solution in healthcare . , Since it first ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer diagnostics workflow solution provider ... 20 – 22 in San Francisco. As part of the Tri-Conference expo, which ... workflow solution, as well as its new precision medicine platform, “Crosswalk Insight: Oncology™.” ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... the development and commercialization of innovative therapies for ... Vincent J. Angotti has been appointed ... company,s board of directors, effective Monday, March 6, ... experience leading executive and commercial teams at public ...
(Date:2/16/2017)... , Feb. 16, 2017  Prescription pain medications ... department visit are necessary for long-term opioid use to ... Feb. 16 th edition of The New ... "Emergency physicians see more patients in acute pain than ... Parker , MD, FACEP, president of the American College ...
(Date:2/16/2017)... Research and Markets has announced the addition of the ... Function, Application, Cancer Type, Technology - Forecast to 2025" report ... ... grow at a CAGR of around 28.6% over the next decade ... Some of the prominent trends that the market is witnessing include ...
Breaking Medicine Technology: